Replacement, Refinement, Reduction
InnoSer’s operation is based on responsibility, using the 3R’s concept – Replacement, Reduction and Refinement.
InnoSer strongly invests in a service portfolio of in vitro assays based on organoid technology, not only to allow a fast and reliable screening model but also to reduce the number of animal usage in the drug discovery and preclinical drug development.
In addition, efficient breeding of genetically altered (GA) rodents will ultimately lead to less animals born compared to the current situation with identical GA breeding colonies being kept at different institutes. InnoSer’s quality concept facilitates the exchange of animals between institutes without the need for rederivation, also contributing to reduction and refinement of laboratory animal usage.